G R Breese

Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

G R Breese, Anna Baumeister, Thomas J. McCown et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 295 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Pharmacokinetics of methylphenidate in man, rat and monkey.

William A. Wargin, Kennerly S. Patrick, Clinton D. Kilts et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 224 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

G R Breese, G E Duncan, T. Celeste Napier et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 212 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Pharmacology of the enantiomers of threo-methylphenidate.

Kennerly S. Patrick, Robert W. Caldwell, R M Ferris et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 197 citations

Medicine, Neuroscience, Pharmacology +14

Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.

G R Breese, Anna Baumeister, T. Celeste Napier et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 151 citations

Medicine, Neuroscience, Pharmacology +16